Insider · CIK 0001648010

Young Diane C.

Reports to the SEC for 2 companies · HAMPTON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001648010

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-25	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP, CHIEF MEDICAL OFFICER	AAward	+57K sh	—	—	57,000
2025-06-05	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP, CHIEF MEDICAL OFFICER	AAward	+72K sh	—	—	72,000
2024-06-13	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP, CHIEF MEDICAL OFFICER	AAward	+72K sh	—	—	72,000
2024-06-11	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP, CHIEF MEDICAL OFFICER	MExercise/Conversion	+15K sh	$2.71	+$40.7K	17,115
2024-06-11	CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionM Exercise/Conversion	SVP, CHIEF MEDICAL OFFICER	MExercise/Conversion	−15K sh	—	—	0
2024-06-07	CLDXCelldex Therapeutics, Inc.S Sale	SVP, CHIEF MEDICAL OFFICER	SSale	−45K sh	$35.26	−$1.59M	2,115
2023-06-15	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP, CHIEF MEDICAL OFFICER	AAward	+80K sh	—	—	80,000
2022-08-17	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP, CHIEF MEDICAL OFFICER	MExercise/Conversion	+19K sh	$10.38	+$197K	21,115
2022-08-17	CLDXCelldex Therapeutics, Inc.S Sale	SVP, CHIEF MEDICAL OFFICER	SSale	−19K sh	$37.30	−$709K	2,115
2022-08-17	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP, CHIEF MEDICAL OFFICER	MExercise/Conversion	+45K sh	$2.71	+$122K	47,115
2022-08-17	CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionM Exercise/Conversion	SVP, CHIEF MEDICAL OFFICER	MExercise/Conversion	−19K sh	—	—	48,400
2022-08-17	CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionM Exercise/Conversion	SVP, CHIEF MEDICAL OFFICER	MExercise/Conversion	−45K sh	—	—	15,000
2022-06-16	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP, CHIEF MEDICAL OFFICER	AAward	+76K sh	—	—	76,000
2021-11-12	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP, CHIEF MEDICAL OFFICER	MExercise/Conversion	+4,600 sh	$10.38	+$47.7K	6,715
2021-11-12	CLDXCelldex Therapeutics, Inc.S Sale	SVP, CHIEF MEDICAL OFFICER	SSale	−4,600 sh	$42.94	−$198K	2,115
2021-11-12	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP, CHIEF MEDICAL OFFICER	MExercise/Conversion	−4,600 sh	—	—	67,400
2021-06-17	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP, CHIEF MEDICAL OFFICER	AAward	+72K sh	—	—	72,000
2020-06-18	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP, CHIEF MEDICAL OFFICER	AAward	+72K sh	—	—	72,000
2020-06-11	CLDXCelldex Therapeutics, Inc.P Purchase	SVP, CHIEF MEDICAL OFFICER	PPurchase	+2,115 sh	$4.73	+$10K	2,115
2019-07-08	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP, CHIEF MEDICAL OFFICER	AAward	+60K sh	—	—	60,000
2018-07-16	Oncternal Therapeutics, Inc.S Sale	VP, Chief Medical Officer	SSale	−2,049 sh	$14.70	−$30.1K	45,936
2018-07-16	Oncternal Therapeutics, Inc.S Sale	VP, Chief Medical Officer	SSale	+2,049 sh	$14.70	+$30.1K	45,936
2018-07-13	Oncternal Therapeutics, Inc.F Tax Payment	VP, Chief Medical Officer	FTax Payment	−2,014 sh	$14.92	−$30K	47,985
2018-07-13	Oncternal Therapeutics, Inc.F Tax Payment	VP, Chief Medical Officer	FTax Payment	−2,014 sh	$14.92	−$30K	47,985
2018-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	VP, Chief Medical Officer	AAward	+25K sh	—	—	25,000
2017-02-28	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	VP, Chief Medical Officer	AAward	+50K sh	—	—	50,000
2016-10-28	Oncternal Therapeutics, Inc.S Sale	VP, Chief Medical Officer	SSale	−500 sh	$7.70	−$3,850	0
2016-01-01	Oncternal Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	VP, Chief Medical Officer	AAward	+150K sh	—	—	150,000
2015-07-13	Oncternal Therapeutics, Inc.A Award	VP, Chief Medical Officer	AAward	+500K sh	—	—	500,000

Recent filings

Accepted (ET)
Jun 294
Young Diane C.0001648010-26-000002
SEC(opens sec.gov)
Jun 94
Young Diane C.0001415889-25-016238
SEC(opens sec.gov)
Jun 174
Young Diane C.0001415889-24-017186
SEC(opens sec.gov)
Jun 134
Young Diane C.0001415889-24-016651
SEC(opens sec.gov)
Jun 114
Young Diane C.0001415889-24-016344
SEC(opens sec.gov)
Jun 204
Young Diane C.0001415889-23-010049
SEC(opens sec.gov)
Aug 194
Young Diane C.0001415889-22-008895
SEC(opens sec.gov)
Jun 174
Young Diane C.0001415889-22-006726
SEC(opens sec.gov)
Nov 164
Young Diane C.0001179110-21-010165
SEC(opens sec.gov)
Jun 214
Young Diane C.0001179110-21-006911
SEC(opens sec.gov)
Jun 194
Young Diane C.0001179110-20-007592
SEC(opens sec.gov)
Jun 124
Young Diane C.0001179110-20-007242
SEC(opens sec.gov)
Jul 94
Young Diane C.0001179110-19-008540
SEC(opens sec.gov)

Companies

Address

C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220

HAMPTON, NJ, 08827